相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Longitudinal trends and subgroup analysis in publication patterns for preclinical data of newly approved drugs
Ursula Koster et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2016)
A comprehensive review of the pharmacodynamics of the SGLT2 inhibitor empagliflozin in animals and humans
Martin C. Michel et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2015)
GPCR structure, function, drug discovery and crystallography: report from Academia-Industry International Conference (UK Royal Society) Chicheley Hall, 1-2 September 2014
Alexander Heifetz et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2015)
Expectations and satisfaction of academic investigators in nonclinical collaboration with the pharmaceutical industry
Marjan Amiri et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2015)
Grants4Targets: an open innovation initiative to foster drug discovery collaborations
Heidrun Dorsch et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Editorial: The Innovative Medicines Initiative - collaborations are key to innovating R&D processes
Hugh Laverty et al.
BIOTECHNOLOGY JOURNAL (2014)
Playing Well with Others! Initiating and Sustaining Successful Collaborations between Industry, Academia and Government
Craig J. Thomas et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2014)
Common misconceptions about data analysis and statistics
Harvey J. Motulsky
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2014)
How significant are your data? The need for a culture shift
Martin C. Michel
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2014)
A comprehensive review of the preclinical efficacy profile of the ErbB family blocker afatinib in cancer
Helmout Modjtahedi et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2014)
Public-Private Partnership: A New Engine for Translational Research in Neurosciences
Declan G. M. Murphy et al.
NEURON (2014)
Bradykinin Contracts Rat Urinary Bladder Largely Independently of Phospholipase C
Carsten Sand et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Unique binding behavior of the recently approved angiotensin II receptor blocker azilsartan compared with that of candesartan
Shin-ichiro Miura et al.
HYPERTENSION RESEARCH (2013)
A comprehensive review of the pharmacodynamics, pharmacokinetics, and clinical effects of the neutral endopeptidase inhibitor racecadotril
Marion Eberlin et al.
FRONTIERS IN PHARMACOLOGY (2012)
In Vitro Antagonistic Properties of a New Angiotensin Type 1 Receptor Blocker, Azilsartan, in Receptor Binding and Function Studies
Mami Ojima et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Drug discovery: new models for industry-academic partnerships
Cathy J. Tralau-Stewart et al.
DRUG DISCOVERY TODAY (2009)
Publication of Clinical Trials Supporting Successful New Drug Applications: A Literature Analysis
Kirby Lee et al.
PLOS MEDICINE (2008)
Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and Presentation
Kristin Rising et al.
PLOS MEDICINE (2008)
PARTNERSHIP AND INNOVATION IN THE LIFE SCIENCES
Dominique Kleyn et al.
INTERNATIONAL JOURNAL OF INNOVATION MANAGEMENT (2007)
TAK-536, a new AT1 receptor blocker, improves glucose intolerance and adipocyte differentiation
Masaru Iwai et al.
AMERICAN JOURNAL OF HYPERTENSION (2007)
Evidence b(i)ased medicine-selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications
H Melander et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
分享论文
